Uganda's Covid-19 Response Hampered By 'Overpriced' Vaccine

The government's plan to procure 18 million doses of Covid-19 vaccine to cater for nine million Ugandans seems to have come at a heavier price than first thought. The costing of one dose of the Oxford-AstraZeneca vaccine has caused an outcry among medical experts and the public, with some accusing the health ministry of inflating the prices. The country will reportedly pay U.S.$7 per dose for the Oxford-AstraZeneca vaccine, while South Africa is paying U.S.$5.25 and the EU U.S.$2.16. The planned rollout will see the vaccine administered to people aged 50 and above, those with underlying health conditions, health workers, security personnel, teachers and other essential social services providers. The cost of the vaccine does not include international transportation and handling costs. As of February 11, 2021 Uganda has recorded 39,911 Covid-19 cases, 14,470 recoveries and 328 deaths.

InFocus

(file photo).

AllAfrica publishes around 800 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.

X